Drug Development Services
-
Comprehensive Analytical Services To Support Development Programs
3/22/2022
IDT Biologika offers comprehensive analytical services to support our clients’ development programs covering viral testing, microbiological testing, molecular-biological testing, biological testing, and chemical-physical testing. For statistical analysis and risk analysis, specialists support the professional groups.
-
Viral Vector Contract Testing, Development, & Manufacturing Services (CTDMO)
9/7/2023
ADVANCING CELL AND GENE THERAPIES FOR PATIENTS
Millipore® CTDMO Services delivers expertise and flexible solutions for viral vector development and manufacturing to advance cell and gene therapies from preclinical through commercial production.
-
Controlled Expansion Of Supercritical Solutions (CESS®) Technology
4/24/2023
Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.
-
Commercial Manufacturing Of APIs, Intermediates, KSMs, RSMs
Leveraging reliable, cost-effective commercial manufacturing solutions with innovative technology and facilities, as well as industry expertise, helps to improve consistency in quality, purity, and potency.
-
SUREtechnology Platform™
8/4/2023
Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.
-
Antibody-Drug Conjugate
1/25/2024
EirGenix provides client-oriented contract development and manufacturing services for biologics, especially monoclonal antibodies and biosimilars. Combining the capabilities of EirGenix’s strategic partner, Formosa Laboratories, Inc, a high potency API manufacturer, we offer integrated services for Antibody Drug Conjugate (ADC) development and manufacturing.
-
Pharmaceutical Development
4/24/2023
Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.
-
Analytical Development
2/17/2022
AGC Biologics develops analytical methods for product release, product characterization and process development support. Robust and validated release methods, including bioassays, are developed to ensure the identity, safety, purity and potency of your product.
Our in-house bioassay group specializes in development and validation of cell-based assays. This speeds results and eliminates the need for third party interactions.
-
Scale Your Vaccine With Path-To-PAD
3/1/2024
The COVID-19 pandemic highlighted the urgent need for a quick, efficient, and scalable vaccine production process. Resilience's Vaccine Path-To-PAD (Process and Analytical Development) program provides a clear and easy path to maximize yields at the beginning of development, with deep expertise in vaccines, robust expression platforms, and high-quality Vero and Quail cell lines.
-
GMP Manufacturing
4/24/2023
Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards.